Trial
NCT02527421
DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Primus Pharmaceuticals
Collaborators
Prosoft Clinical
Condition
Plaque Psoriasis
Intervention
DFD01 Spray
Why stopped
Not able to recruit patients with the current enrollment criteria.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-07